Print Page     Close Window     

News Releases


2019 | 2018 | 2017 | Archive
Keyword Search
 
DateTitle 
03/04/19ACADIA Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on March 11, 2019
SAN DIEGO--(BUSINESS WIRE)--Mar. 4, 2019-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019, at 11:20 a.m. Eastern Time in New York City. A live webcast o... 
Printer Friendly Version
02/26/19ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
- Fourth Quarter 2018 Net Sales Grew to $59.6 Million, a 37% Increase Over 4Q17 - Full Year 2018 Net Sales Grew to $223.8 Million, a 79% Increase Over Full Year 2017 - Late Stage Pipeline Progressing with Five Clinical Programs Ongoing or Commencing in 2019 - 2019 Guidance: Net Sales $275 Million to $300 Million SAN DIEGO--(BUSINESS WIRE)--Feb. 26, 2019-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biop... 
Printer Friendly Version
02/21/19ACADIA Pharmaceuticals to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019
SAN DIEGO--(BUSINESS WIRE)--Feb. 21, 2019-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 8th Annual Leerink Partners Global Healthcare Conference on Thursday, February 28, 2019, at 9:30 a.m. Eastern Standard Time in New York City. ... 
Printer Friendly Version
02/12/19ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019
ACADIA to Host Conference Call and Webcast on Tuesday, February 26, 2019, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Feb. 12, 2019-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter and ful... 
Printer Friendly Version